# A Study to Evaluate Efficacy and Safety of Distal Jejunal-release Dextrose Beads Formulation in Subjects With a Pathological Oral Glucose Tolerance Test

> **NCT05803772** · PHASE2 · COMPLETED · sponsor: **Aphaia Pharma US LLC** · enrollment: 31 (actual)

## Conditions studied

- PreDiabetes
- Glucose Tolerance Impaired

## Interventions

- **DRUG:** APHD-012
- **DRUG:** APH-012P

## Key facts

- **NCT ID:** NCT05803772
- **Lead sponsor:** Aphaia Pharma US LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-31
- **Primary completion:** 2024-02-12
- **Final completion:** 2024-02-12
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2024-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05803772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05803772, "A Study to Evaluate Efficacy and Safety of Distal Jejunal-release Dextrose Beads Formulation in Subjects With a Pathological Oral Glucose Tolerance Test". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05803772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*